nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Teniposide—lung cancer	0.129	0.196	CbGbCtD
Ofloxacin—TOP2A—Etoposide—lung cancer	0.0567	0.0865	CbGbCtD
Ofloxacin—ABCC1—Paclitaxel—lung cancer	0.0398	0.0606	CbGbCtD
Ofloxacin—ABCC1—Irinotecan—lung cancer	0.0393	0.0598	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—lung cancer	0.0387	0.059	CbGbCtD
Ofloxacin—ABCC1—Vinblastine—lung cancer	0.0349	0.0532	CbGbCtD
Ofloxacin—ABCC1—Etoposide—lung cancer	0.0314	0.0479	CbGbCtD
Ofloxacin—ABCC2—Paclitaxel—lung cancer	0.0295	0.0449	CbGbCtD
Ofloxacin—ABCC2—Irinotecan—lung cancer	0.0291	0.0443	CbGbCtD
Ofloxacin—ABCC1—Docetaxel—lung cancer	0.0288	0.0438	CbGbCtD
Ofloxacin—ABCC2—Vinblastine—lung cancer	0.0258	0.0394	CbGbCtD
Ofloxacin—ABCC2—Cisplatin—lung cancer	0.0237	0.0361	CbGbCtD
Ofloxacin—ABCC2—Etoposide—lung cancer	0.0233	0.0355	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—lung cancer	0.0214	0.0327	CbGbCtD
Ofloxacin—ABCC2—Docetaxel—lung cancer	0.0213	0.0325	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—lung cancer	0.0208	0.0317	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—lung cancer	0.0159	0.0242	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—lung cancer	0.0154	0.0234	CbGbCtD
Ofloxacin—CYP1A2—Erlotinib—lung cancer	0.012	0.0183	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—lung cancer	0.0113	0.0171	CbGbCtD
Ofloxacin—CYP1A2—Etoposide—lung cancer	0.00868	0.0132	CbGbCtD
Ofloxacin—SLC22A4—mammary gland—lung cancer	0.00118	0.0952	CbGeAlD
Ofloxacin—TOP2A—bronchus—lung cancer	0.000808	0.0652	CbGeAlD
Ofloxacin—SLC22A4—respiratory system—lung cancer	0.000786	0.0634	CbGeAlD
Ofloxacin—SLC22A5—mammary gland—lung cancer	0.00078	0.063	CbGeAlD
Ofloxacin—SLC22A4—bronchus—lung cancer	0.000647	0.0522	CbGeAlD
Ofloxacin—SLC22A4—trachea—lung cancer	0.000581	0.0469	CbGeAlD
Ofloxacin—TOP2A—bone marrow—lung cancer	0.000576	0.0465	CbGeAlD
Ofloxacin—TOP2A—lung—lung cancer	0.000522	0.0421	CbGeAlD
Ofloxacin—SLC22A5—respiratory system—lung cancer	0.00052	0.042	CbGeAlD
Ofloxacin—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000489	0.097	CbGdCrCtD
Ofloxacin—ABCC1—bronchus—lung cancer	0.000487	0.0393	CbGeAlD
Ofloxacin—CYP1A2—respiratory system—lung cancer	0.000471	0.038	CbGeAlD
Ofloxacin—Gatifloxacin—ALB—lung cancer	0.000471	0.244	CrCbGaD
Ofloxacin—SLC22A4—bone marrow—lung cancer	0.000461	0.0372	CbGeAlD
Ofloxacin—Norfloxacin—CYP2A6—lung cancer	0.00045	0.232	CrCbGaD
Ofloxacin—ABCC1—trachea—lung cancer	0.000437	0.0353	CbGeAlD
Ofloxacin—SLC22A5—bronchus—lung cancer	0.000428	0.0346	CbGeAlD
Ofloxacin—TOP2A—Irinotecan—Topotecan—lung cancer	0.000419	0.0831	CbGdCrCtD
Ofloxacin—SLC22A4—lung—lung cancer	0.000417	0.0337	CbGeAlD
Ofloxacin—ABCC1—cardiac atrium—lung cancer	0.000411	0.0331	CbGeAlD
Ofloxacin—SLC22A5—trachea—lung cancer	0.000384	0.031	CbGeAlD
Ofloxacin—TOP2A—Erlotinib—Gefitinib—lung cancer	0.000365	0.0725	CbGdCrCtD
Ofloxacin—SLC22A5—cardiac atrium—lung cancer	0.000361	0.0291	CbGeAlD
Ofloxacin—TOP2A—lymph node—lung cancer	0.000357	0.0288	CbGeAlD
Ofloxacin—TOP2A—Topotecan—Irinotecan—lung cancer	0.000348	0.069	CbGdCrCtD
Ofloxacin—TOP2A—Etoposide—Teniposide—lung cancer	0.000346	0.0686	CbGdCrCtD
Ofloxacin—Norfloxacin—CYP1A1—lung cancer	0.000315	0.163	CrCbGaD
Ofloxacin—ABCC1—lung—lung cancer	0.000314	0.0253	CbGeAlD
Ofloxacin—TOP2A—Vindesine—Vinorelbine—lung cancer	0.000311	0.0617	CbGdCrCtD
Ofloxacin—Sparfloxacin—ABCB1—lung cancer	0.000293	0.152	CrCbGaD
Ofloxacin—SLC22A4—lymph node—lung cancer	0.000285	0.023	CbGeAlD
Ofloxacin—SLC22A5—lung—lung cancer	0.000276	0.0223	CbGeAlD
Ofloxacin—TOP2A—Podofilox—Teniposide—lung cancer	0.000264	0.0523	CbGdCrCtD
Ofloxacin—CYP1A2—lung—lung cancer	0.00025	0.0202	CbGeAlD
Ofloxacin—TOP2A—Vindesine—Vinblastine—lung cancer	0.000249	0.0493	CbGdCrCtD
Ofloxacin—TOP2A—Methotrexate—Pemetrexed—lung cancer	0.000248	0.0492	CbGdCrCtD
Ofloxacin—TOP2A—Paclitaxel—Docetaxel—lung cancer	0.000244	0.0484	CbGdCrCtD
Ofloxacin—ABCC2—lymph node—lung cancer	0.000244	0.0197	CbGeAlD
Ofloxacin—TOP2A—Afatinib—Gefitinib—lung cancer	0.000239	0.0474	CbGdCrCtD
Ofloxacin—TOP2A—Gefitinib—Erlotinib—lung cancer	0.000234	0.0465	CbGdCrCtD
Ofloxacin—ABCC1—lymph node—lung cancer	0.000215	0.0173	CbGeAlD
Ofloxacin—Levofloxacin—ABCB1—lung cancer	0.000206	0.107	CrCbGaD
Ofloxacin—Ciprofloxacin—ABCB1—lung cancer	0.000199	0.103	CrCbGaD
Ofloxacin—SLC22A5—lymph node—lung cancer	0.000189	0.0152	CbGeAlD
Ofloxacin—TOP2A—Vincristine—Vinorelbine—lung cancer	0.000168	0.0333	CbGdCrCtD
Ofloxacin—TOP2A—Vinorelbine—Vinblastine—lung cancer	0.000157	0.0311	CbGdCrCtD
Ofloxacin—TOP2A—Podofilox—Etoposide—lung cancer	0.000157	0.0311	CbGdCrCtD
Ofloxacin—TOP2A—Teniposide—Etoposide—lung cancer	0.000157	0.0311	CbGdCrCtD
Ofloxacin—TOP2A—Vinblastine—Vinorelbine—lung cancer	0.000135	0.0268	CbGdCrCtD
Ofloxacin—TOP2A—Vincristine—Vinblastine—lung cancer	0.000134	0.0266	CbGdCrCtD
Ofloxacin—TOP2A—Cytarabine—Gemcitabine—lung cancer	8.82e-05	0.0175	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—lung cancer	7.57e-05	0.015	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—lung cancer	7.57e-05	0.015	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—lung cancer	7.57e-05	0.015	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Gemcitabine—lung cancer	6.32e-05	0.0125	CbGdCrCtD
Ofloxacin—Infection—Docetaxel—lung cancer	4.28e-05	0.000176	CcSEcCtD
Ofloxacin—Weight decreased—Doxorubicin—lung cancer	4.28e-05	0.000176	CcSEcCtD
Ofloxacin—Feeling abnormal—Etoposide—lung cancer	4.27e-05	0.000175	CcSEcCtD
Ofloxacin—Hyperglycaemia—Doxorubicin—lung cancer	4.27e-05	0.000175	CcSEcCtD
Ofloxacin—Diarrhoea—Irinotecan—lung cancer	4.26e-05	0.000175	CcSEcCtD
Ofloxacin—Pneumonia—Doxorubicin—lung cancer	4.24e-05	0.000174	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Etoposide—lung cancer	4.24e-05	0.000174	CcSEcCtD
Ofloxacin—Shock—Docetaxel—lung cancer	4.24e-05	0.000174	CcSEcCtD
Ofloxacin—Nervous system disorder—Docetaxel—lung cancer	4.23e-05	0.000173	CcSEcCtD
Ofloxacin—Thrombocytopenia—Docetaxel—lung cancer	4.22e-05	0.000173	CcSEcCtD
Ofloxacin—Infestation NOS—Doxorubicin—lung cancer	4.22e-05	0.000173	CcSEcCtD
Ofloxacin—Infestation—Doxorubicin—lung cancer	4.22e-05	0.000173	CcSEcCtD
Ofloxacin—Drowsiness—Doxorubicin—lung cancer	4.22e-05	0.000173	CcSEcCtD
Ofloxacin—Visual impairment—Methotrexate—lung cancer	4.21e-05	0.000173	CcSEcCtD
Ofloxacin—Tachycardia—Docetaxel—lung cancer	4.21e-05	0.000173	CcSEcCtD
Ofloxacin—Feeling abnormal—Paclitaxel—lung cancer	4.19e-05	0.000172	CcSEcCtD
Ofloxacin—Skin disorder—Docetaxel—lung cancer	4.19e-05	0.000172	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	4.18e-05	0.000172	CcSEcCtD
Ofloxacin—Hypersensitivity—Cisplatin—lung cancer	4.17e-05	0.000171	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Paclitaxel—lung cancer	4.16e-05	0.000171	CcSEcCtD
Ofloxacin—Diarrhoea—Gemcitabine—lung cancer	4.15e-05	0.00017	CcSEcCtD
Ofloxacin—Renal failure—Doxorubicin—lung cancer	4.14e-05	0.00017	CcSEcCtD
Ofloxacin—Erythema multiforme—Methotrexate—lung cancer	4.13e-05	0.00017	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Doxorubicin—lung cancer	4.13e-05	0.00017	CcSEcCtD
Ofloxacin—Dizziness—Irinotecan—lung cancer	4.12e-05	0.000169	CcSEcCtD
Ofloxacin—Urticaria—Etoposide—lung cancer	4.12e-05	0.000169	CcSEcCtD
Ofloxacin—Jaundice—Doxorubicin—lung cancer	4.11e-05	0.000169	CcSEcCtD
Ofloxacin—Stomatitis—Doxorubicin—lung cancer	4.11e-05	0.000169	CcSEcCtD
Ofloxacin—Anorexia—Docetaxel—lung cancer	4.11e-05	0.000169	CcSEcCtD
Ofloxacin—Abdominal pain—Etoposide—lung cancer	4.1e-05	0.000168	CcSEcCtD
Ofloxacin—Body temperature increased—Etoposide—lung cancer	4.1e-05	0.000168	CcSEcCtD
Ofloxacin—Conjunctivitis—Doxorubicin—lung cancer	4.1e-05	0.000168	CcSEcCtD
Ofloxacin—Eye disorder—Methotrexate—lung cancer	4.08e-05	0.000168	CcSEcCtD
Ofloxacin—Tinnitus—Methotrexate—lung cancer	4.08e-05	0.000167	CcSEcCtD
Ofloxacin—Asthenia—Cisplatin—lung cancer	4.06e-05	0.000167	CcSEcCtD
Ofloxacin—Cardiac disorder—Methotrexate—lung cancer	4.06e-05	0.000166	CcSEcCtD
Ofloxacin—Urticaria—Paclitaxel—lung cancer	4.04e-05	0.000166	CcSEcCtD
Ofloxacin—Hypotension—Docetaxel—lung cancer	4.03e-05	0.000165	CcSEcCtD
Ofloxacin—Haematuria—Doxorubicin—lung cancer	4.02e-05	0.000165	CcSEcCtD
Ofloxacin—Body temperature increased—Paclitaxel—lung cancer	4.02e-05	0.000165	CcSEcCtD
Ofloxacin—Abdominal pain—Paclitaxel—lung cancer	4.02e-05	0.000165	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Doxorubicin—lung cancer	3.99e-05	0.000164	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—lung cancer	3.98e-05	0.000163	CcSEcCtD
Ofloxacin—Angiopathy—Methotrexate—lung cancer	3.97e-05	0.000163	CcSEcCtD
Ofloxacin—Vomiting—Irinotecan—lung cancer	3.96e-05	0.000163	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—lung cancer	3.96e-05	0.000162	CcSEcCtD
Ofloxacin—Immune system disorder—Methotrexate—lung cancer	3.95e-05	0.000162	CcSEcCtD
Ofloxacin—Mediastinal disorder—Methotrexate—lung cancer	3.94e-05	0.000162	CcSEcCtD
Ofloxacin—Agranulocytosis—Doxorubicin—lung cancer	3.93e-05	0.000161	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CNDP2—lung cancer	3.93e-05	0.000487	CbGpPWpGaD
Ofloxacin—Rash—Irinotecan—lung cancer	3.93e-05	0.000161	CcSEcCtD
Ofloxacin—Dermatitis—Irinotecan—lung cancer	3.93e-05	0.000161	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Docetaxel—lung cancer	3.93e-05	0.000161	CcSEcCtD
Ofloxacin—Chills—Methotrexate—lung cancer	3.92e-05	0.000161	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.91e-05	0.000484	CbGpPWpGaD
Ofloxacin—Headache—Irinotecan—lung cancer	3.9e-05	0.00016	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—CYP2E1—lung cancer	3.9e-05	0.000483	CbGpPWpGaD
Ofloxacin—Insomnia—Docetaxel—lung cancer	3.9e-05	0.00016	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	3.87e-05	0.000479	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	3.87e-05	0.000479	CbGpPWpGaD
Ofloxacin—Diarrhoea—Cisplatin—lung cancer	3.87e-05	0.000159	CcSEcCtD
Ofloxacin—Paraesthesia—Docetaxel—lung cancer	3.87e-05	0.000159	CcSEcCtD
Ofloxacin—Alopecia—Methotrexate—lung cancer	3.86e-05	0.000158	CcSEcCtD
Ofloxacin—Vomiting—Gemcitabine—lung cancer	3.86e-05	0.000158	CcSEcCtD
Ofloxacin—Bradycardia—Doxorubicin—lung cancer	3.85e-05	0.000158	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	3.85e-05	0.000476	CbGpPWpGaD
Ofloxacin—Dyspnoea—Docetaxel—lung cancer	3.84e-05	0.000158	CcSEcCtD
Ofloxacin—Somnolence—Docetaxel—lung cancer	3.83e-05	0.000157	CcSEcCtD
Ofloxacin—Mental disorder—Methotrexate—lung cancer	3.83e-05	0.000157	CcSEcCtD
Ofloxacin—Rash—Gemcitabine—lung cancer	3.83e-05	0.000157	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—MTMR3—lung cancer	3.83e-05	0.000474	CbGpPWpGaD
Ofloxacin—Dermatitis—Gemcitabine—lung cancer	3.82e-05	0.000157	CcSEcCtD
Ofloxacin—Hypersensitivity—Etoposide—lung cancer	3.82e-05	0.000157	CcSEcCtD
Ofloxacin—Malnutrition—Methotrexate—lung cancer	3.81e-05	0.000156	CcSEcCtD
Ofloxacin—Erythema—Methotrexate—lung cancer	3.81e-05	0.000156	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—lung cancer	3.8e-05	0.000156	CcSEcCtD
Ofloxacin—Headache—Gemcitabine—lung cancer	3.8e-05	0.000156	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—lung cancer	3.79e-05	0.000156	CcSEcCtD
Ofloxacin—Dyspepsia—Docetaxel—lung cancer	3.79e-05	0.000156	CcSEcCtD
Ofloxacin—Hepatitis—Doxorubicin—lung cancer	3.78e-05	0.000155	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—lung cancer	3.78e-05	0.000155	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	3.77e-05	0.000467	CbGpPWpGaD
Ofloxacin—Hypoaesthesia—Doxorubicin—lung cancer	3.77e-05	0.000155	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	3.77e-05	0.000466	CbGpPWpGaD
Ofloxacin—Pharyngitis—Doxorubicin—lung cancer	3.76e-05	0.000154	CcSEcCtD
Ofloxacin—Decreased appetite—Docetaxel—lung cancer	3.75e-05	0.000154	CcSEcCtD
Ofloxacin—Hypersensitivity—Paclitaxel—lung cancer	3.75e-05	0.000154	CcSEcCtD
Ofloxacin—Urinary tract disorder—Doxorubicin—lung cancer	3.74e-05	0.000153	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—PGAM1—lung cancer	3.73e-05	0.000462	CbGpPWpGaD
Ofloxacin—Oedema peripheral—Doxorubicin—lung cancer	3.73e-05	0.000153	CcSEcCtD
Ofloxacin—Dysgeusia—Methotrexate—lung cancer	3.73e-05	0.000153	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	3.73e-05	0.000461	CbGpPWpGaD
Ofloxacin—Gastrointestinal disorder—Docetaxel—lung cancer	3.72e-05	0.000153	CcSEcCtD
Ofloxacin—Asthenia—Etoposide—lung cancer	3.72e-05	0.000153	CcSEcCtD
Ofloxacin—Connective tissue disorder—Doxorubicin—lung cancer	3.72e-05	0.000153	CcSEcCtD
Ofloxacin—Fatigue—Docetaxel—lung cancer	3.71e-05	0.000152	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—lung cancer	3.71e-05	0.000152	CcSEcCtD
Ofloxacin—Nausea—Irinotecan—lung cancer	3.7e-05	0.000152	CcSEcCtD
Ofloxacin—Constipation—Docetaxel—lung cancer	3.68e-05	0.000151	CcSEcCtD
Ofloxacin—Pain—Docetaxel—lung cancer	3.68e-05	0.000151	CcSEcCtD
Ofloxacin—Back pain—Methotrexate—lung cancer	3.68e-05	0.000151	CcSEcCtD
Ofloxacin—Pruritus—Etoposide—lung cancer	3.67e-05	0.000151	CcSEcCtD
Ofloxacin—ABCC1—Disease—SKI—lung cancer	3.67e-05	0.000454	CbGpPWpGaD
Ofloxacin—Visual impairment—Doxorubicin—lung cancer	3.65e-05	0.00015	CcSEcCtD
Ofloxacin—Asthenia—Paclitaxel—lung cancer	3.65e-05	0.00015	CcSEcCtD
Ofloxacin—Nausea—Gemcitabine—lung cancer	3.61e-05	0.000148	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—CREBBP—lung cancer	3.6e-05	0.000446	CbGpPWpGaD
Ofloxacin—Vomiting—Cisplatin—lung cancer	3.6e-05	0.000148	CcSEcCtD
Ofloxacin—Pruritus—Paclitaxel—lung cancer	3.6e-05	0.000148	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.59e-05	0.000444	CbGpPWpGaD
Ofloxacin—Vision blurred—Methotrexate—lung cancer	3.59e-05	0.000147	CcSEcCtD
Ofloxacin—Erythema multiforme—Doxorubicin—lung cancer	3.58e-05	0.000147	CcSEcCtD
Ofloxacin—Rash—Cisplatin—lung cancer	3.57e-05	0.000146	CcSEcCtD
Ofloxacin—Dermatitis—Cisplatin—lung cancer	3.56e-05	0.000146	CcSEcCtD
Ofloxacin—ABCC1—Disease—B4GALT5—lung cancer	3.56e-05	0.000441	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP2A7—lung cancer	3.56e-05	0.00044	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Docetaxel—lung cancer	3.55e-05	0.000146	CcSEcCtD
Ofloxacin—Diarrhoea—Etoposide—lung cancer	3.55e-05	0.000146	CcSEcCtD
Ofloxacin—Eye disorder—Doxorubicin—lung cancer	3.54e-05	0.000145	CcSEcCtD
Ofloxacin—Ill-defined disorder—Methotrexate—lung cancer	3.53e-05	0.000145	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—lung cancer	3.53e-05	0.000145	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Docetaxel—lung cancer	3.52e-05	0.000145	CcSEcCtD
Ofloxacin—Anaemia—Methotrexate—lung cancer	3.52e-05	0.000144	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—lung cancer	3.51e-05	0.000144	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—lung cancer	3.51e-05	0.000144	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—SDC4—lung cancer	3.48e-05	0.000431	CbGpPWpGaD
Ofloxacin—Diarrhoea—Paclitaxel—lung cancer	3.48e-05	0.000143	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.47e-05	0.00043	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	3.47e-05	0.00043	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	3.43e-05	0.000425	CbGpPWpGaD
Ofloxacin—Angiopathy—Doxorubicin—lung cancer	3.43e-05	0.000141	CcSEcCtD
Ofloxacin—Malaise—Methotrexate—lung cancer	3.43e-05	0.000141	CcSEcCtD
Ofloxacin—Dizziness—Etoposide—lung cancer	3.43e-05	0.000141	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—lung cancer	3.42e-05	0.00014	CcSEcCtD
Ofloxacin—Vertigo—Methotrexate—lung cancer	3.42e-05	0.00014	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—lung cancer	3.41e-05	0.00014	CcSEcCtD
Ofloxacin—Abdominal pain—Docetaxel—lung cancer	3.41e-05	0.00014	CcSEcCtD
Ofloxacin—Body temperature increased—Docetaxel—lung cancer	3.41e-05	0.00014	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—lung cancer	3.41e-05	0.00014	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—lung cancer	3.4e-05	0.000139	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	3.39e-05	0.00042	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	3.39e-05	0.00042	CbGpPWpGaD
Ofloxacin—Arrhythmia—Doxorubicin—lung cancer	3.38e-05	0.000139	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—lung cancer	3.37e-05	0.000418	CbGpPWpGaD
Ofloxacin—Dizziness—Paclitaxel—lung cancer	3.36e-05	0.000138	CcSEcCtD
Ofloxacin—Nausea—Cisplatin—lung cancer	3.36e-05	0.000138	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—lung cancer	3.34e-05	0.000137	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—lung cancer	3.33e-05	0.000413	CbGpPWpGaD
Ofloxacin—Cough—Methotrexate—lung cancer	3.32e-05	0.000136	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—lung cancer	3.32e-05	0.000136	CcSEcCtD
Ofloxacin—Vomiting—Etoposide—lung cancer	3.3e-05	0.000135	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—lung cancer	3.29e-05	0.000135	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—lung cancer	3.29e-05	0.000135	CcSEcCtD
Ofloxacin—Rash—Etoposide—lung cancer	3.27e-05	0.000134	CcSEcCtD
Ofloxacin—Dermatitis—Etoposide—lung cancer	3.27e-05	0.000134	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	3.26e-05	0.000404	CbGpPWpGaD
Ofloxacin—Headache—Etoposide—lung cancer	3.25e-05	0.000133	CcSEcCtD
Ofloxacin—Flatulence—Doxorubicin—lung cancer	3.25e-05	0.000133	CcSEcCtD
Ofloxacin—Myalgia—Methotrexate—lung cancer	3.24e-05	0.000133	CcSEcCtD
Ofloxacin—Chest pain—Methotrexate—lung cancer	3.24e-05	0.000133	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—lung cancer	3.24e-05	0.000133	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—lung cancer	3.23e-05	0.000133	CcSEcCtD
Ofloxacin—Vomiting—Paclitaxel—lung cancer	3.23e-05	0.000133	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—lung cancer	3.23e-05	0.000132	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—GSTP1—lung cancer	3.22e-05	0.000398	CbGpPWpGaD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.22e-05	0.000132	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	3.21e-05	0.000397	CbGpPWpGaD
Ofloxacin—Rash—Paclitaxel—lung cancer	3.21e-05	0.000132	CcSEcCtD
Ofloxacin—Dermatitis—Paclitaxel—lung cancer	3.2e-05	0.000131	CcSEcCtD
Ofloxacin—Discomfort—Methotrexate—lung cancer	3.2e-05	0.000131	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—lung cancer	3.2e-05	0.000131	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—lung cancer	3.2e-05	0.000396	CbGpPWpGaD
Ofloxacin—Back pain—Doxorubicin—lung cancer	3.19e-05	0.000131	CcSEcCtD
Ofloxacin—Headache—Paclitaxel—lung cancer	3.18e-05	0.000131	CcSEcCtD
Ofloxacin—ABCC1—Disease—PXN—lung cancer	3.18e-05	0.000394	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Docetaxel—lung cancer	3.17e-05	0.00013	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	3.17e-05	0.000393	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—RRM1—lung cancer	3.17e-05	0.000393	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTA3—lung cancer	3.17e-05	0.000393	CbGpPWpGaD
Ofloxacin—Muscle spasms—Doxorubicin—lung cancer	3.17e-05	0.00013	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	3.16e-05	0.000391	CbGpPWpGaD
Ofloxacin—Confusional state—Methotrexate—lung cancer	3.13e-05	0.000128	CcSEcCtD
Ofloxacin—ABCC1—Disease—AKR1C1—lung cancer	3.12e-05	0.000386	CbGpPWpGaD
Ofloxacin—Anaphylactic shock—Methotrexate—lung cancer	3.11e-05	0.000127	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—lung cancer	3.11e-05	0.000127	CcSEcCtD
Ofloxacin—Asthenia—Docetaxel—lung cancer	3.09e-05	0.000127	CcSEcCtD
Ofloxacin—Infection—Methotrexate—lung cancer	3.09e-05	0.000127	CcSEcCtD
Ofloxacin—Nausea—Etoposide—lung cancer	3.08e-05	0.000126	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—RB1—lung cancer	3.07e-05	0.00038	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—AVP—lung cancer	3.06e-05	0.000379	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	3.06e-05	0.000379	CbGpPWpGaD
Ofloxacin—Ill-defined disorder—Doxorubicin—lung cancer	3.06e-05	0.000125	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—RAF1—lung cancer	3.05e-05	0.000378	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—lung cancer	3.05e-05	0.000378	CbGpPWpGaD
Ofloxacin—Pruritus—Docetaxel—lung cancer	3.05e-05	0.000125	CcSEcCtD
Ofloxacin—Nervous system disorder—Methotrexate—lung cancer	3.05e-05	0.000125	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—lung cancer	3.05e-05	0.000125	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—lung cancer	3.04e-05	0.000125	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—lung cancer	3.03e-05	0.000124	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—AVP—lung cancer	3.02e-05	0.000374	CbGpPWpGaD
Ofloxacin—Nausea—Paclitaxel—lung cancer	3.02e-05	0.000124	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	3.02e-05	0.000374	CbGpPWpGaD
Ofloxacin—Skin disorder—Methotrexate—lung cancer	3.02e-05	0.000124	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—lung cancer	3e-05	0.000123	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—B4GALT5—lung cancer	2.98e-05	0.000369	CbGpPWpGaD
Ofloxacin—Malaise—Doxorubicin—lung cancer	2.97e-05	0.000122	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—lung cancer	2.96e-05	0.000367	CbGpPWpGaD
Ofloxacin—Vertigo—Doxorubicin—lung cancer	2.96e-05	0.000121	CcSEcCtD
Ofloxacin—Anorexia—Methotrexate—lung cancer	2.96e-05	0.000121	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—GSTM1—lung cancer	2.96e-05	0.000366	CbGpPWpGaD
Ofloxacin—Syncope—Doxorubicin—lung cancer	2.95e-05	0.000121	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—lung cancer	2.95e-05	0.000121	CcSEcCtD
Ofloxacin—Diarrhoea—Docetaxel—lung cancer	2.95e-05	0.000121	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.93e-05	0.000363	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCB1—lung cancer	2.93e-05	0.000363	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	2.92e-05	0.000361	CbGpPWpGaD
Ofloxacin—Palpitations—Doxorubicin—lung cancer	2.91e-05	0.000119	CcSEcCtD
Ofloxacin—Hypotension—Methotrexate—lung cancer	2.9e-05	0.000119	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—GSTA4—lung cancer	2.9e-05	0.000359	CbGpPWpGaD
Ofloxacin—Loss of consciousness—Doxorubicin—lung cancer	2.9e-05	0.000119	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—lung cancer	2.88e-05	0.000118	CcSEcCtD
Ofloxacin—ABCC1—Disease—NPPA—lung cancer	2.87e-05	0.000355	CbGpPWpGaD
Ofloxacin—Dizziness—Docetaxel—lung cancer	2.85e-05	0.000117	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—lung cancer	2.84e-05	0.000117	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.83e-05	0.000351	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—lung cancer	2.83e-05	0.000116	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—GSTA2—lung cancer	2.83e-05	0.00035	CbGpPWpGaD
Ofloxacin—Insomnia—Methotrexate—lung cancer	2.81e-05	0.000115	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—lung cancer	2.81e-05	0.000115	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—lung cancer	2.81e-05	0.000115	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—lung cancer	2.81e-05	0.000115	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—CYP1A1—lung cancer	2.8e-05	0.000347	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PPIA—lung cancer	2.8e-05	0.000347	CbGpPWpGaD
Ofloxacin—Anxiety—Doxorubicin—lung cancer	2.8e-05	0.000115	CcSEcCtD
Ofloxacin—Paraesthesia—Methotrexate—lung cancer	2.79e-05	0.000114	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.79e-05	0.000114	CcSEcCtD
Ofloxacin—ABCC1—Disease—ALDOA—lung cancer	2.78e-05	0.000344	CbGpPWpGaD
Ofloxacin—Discomfort—Doxorubicin—lung cancer	2.77e-05	0.000114	CcSEcCtD
Ofloxacin—Dyspnoea—Methotrexate—lung cancer	2.77e-05	0.000114	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	2.76e-05	0.000342	CbGpPWpGaD
Ofloxacin—Somnolence—Methotrexate—lung cancer	2.76e-05	0.000113	CcSEcCtD
Ofloxacin—Dry mouth—Doxorubicin—lung cancer	2.74e-05	0.000113	CcSEcCtD
Ofloxacin—Vomiting—Docetaxel—lung cancer	2.74e-05	0.000112	CcSEcCtD
Ofloxacin—Dyspepsia—Methotrexate—lung cancer	2.73e-05	0.000112	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—GSTA1—lung cancer	2.73e-05	0.000338	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	2.73e-05	0.000337	CbGpPWpGaD
Ofloxacin—Rash—Docetaxel—lung cancer	2.72e-05	0.000111	CcSEcCtD
Ofloxacin—Dermatitis—Docetaxel—lung cancer	2.71e-05	0.000111	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—lung cancer	2.71e-05	0.000111	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—lung cancer	2.71e-05	0.000335	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—lung cancer	2.7e-05	0.000334	CbGpPWpGaD
Ofloxacin—Decreased appetite—Methotrexate—lung cancer	2.7e-05	0.000111	CcSEcCtD
Ofloxacin—Headache—Docetaxel—lung cancer	2.7e-05	0.000111	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ABCC3—lung cancer	2.7e-05	0.000334	CbGpPWpGaD
Ofloxacin—Anaphylactic shock—Doxorubicin—lung cancer	2.69e-05	0.00011	CcSEcCtD
Ofloxacin—Oedema—Doxorubicin—lung cancer	2.69e-05	0.00011	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—lung cancer	2.68e-05	0.00011	CcSEcCtD
Ofloxacin—Fatigue—Methotrexate—lung cancer	2.68e-05	0.00011	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—lung cancer	2.67e-05	0.00011	CcSEcCtD
Ofloxacin—Pain—Methotrexate—lung cancer	2.66e-05	0.000109	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—lung cancer	2.65e-05	0.000109	CcSEcCtD
Ofloxacin—Nervous system disorder—Doxorubicin—lung cancer	2.64e-05	0.000108	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—lung cancer	2.63e-05	0.000108	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—lung cancer	2.62e-05	0.000108	CcSEcCtD
Ofloxacin—ABCC1—Disease—ADCY1—lung cancer	2.62e-05	0.000325	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MDM2—lung cancer	2.62e-05	0.000324	CbGpPWpGaD
Ofloxacin—Skin disorder—Doxorubicin—lung cancer	2.61e-05	0.000107	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—AKR1C1—lung cancer	2.61e-05	0.000323	CbGpPWpGaD
Ofloxacin—Hyperhidrosis—Doxorubicin—lung cancer	2.6e-05	0.000107	CcSEcCtD
Ofloxacin—ABCC1—Disease—ENO2—lung cancer	2.57e-05	0.000319	CbGpPWpGaD
Ofloxacin—Anorexia—Doxorubicin—lung cancer	2.56e-05	0.000105	CcSEcCtD
Ofloxacin—Nausea—Docetaxel—lung cancer	2.56e-05	0.000105	CcSEcCtD
Ofloxacin—Feeling abnormal—Methotrexate—lung cancer	2.56e-05	0.000105	CcSEcCtD
Ofloxacin—ABCC1—Disease—PPP2R1B—lung cancer	2.56e-05	0.000317	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SMARCA4—lung cancer	2.56e-05	0.000317	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	2.55e-05	0.000316	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Methotrexate—lung cancer	2.54e-05	0.000104	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—lung cancer	2.54e-05	0.000314	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—UGT1A1—lung cancer	2.53e-05	0.000314	CbGpPWpGaD
Ofloxacin—Hypotension—Doxorubicin—lung cancer	2.51e-05	0.000103	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	2.47e-05	0.000306	CbGpPWpGaD
Ofloxacin—Urticaria—Methotrexate—lung cancer	2.47e-05	0.000101	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—AZIN2—lung cancer	2.47e-05	0.000305	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—COL4A3BP—lung cancer	2.47e-05	0.000305	CbGpPWpGaD
Ofloxacin—Abdominal pain—Methotrexate—lung cancer	2.45e-05	0.000101	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—lung cancer	2.45e-05	0.000101	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.45e-05	0.000101	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—GNG11—lung cancer	2.44e-05	0.000303	CbGpPWpGaD
Ofloxacin—Insomnia—Doxorubicin—lung cancer	2.43e-05	9.98e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.43e-05	0.000301	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	2.42e-05	0.000299	CbGpPWpGaD
Ofloxacin—Paraesthesia—Doxorubicin—lung cancer	2.41e-05	9.91e-05	CcSEcCtD
Ofloxacin—Dyspnoea—Doxorubicin—lung cancer	2.4e-05	9.84e-05	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—lung cancer	2.39e-05	9.81e-05	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—lung cancer	2.37e-05	9.71e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	2.35e-05	0.000291	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—lung cancer	2.34e-05	0.00029	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ENO1—lung cancer	2.34e-05	0.00029	CbGpPWpGaD
Ofloxacin—Decreased appetite—Doxorubicin—lung cancer	2.34e-05	9.59e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ALDOA—lung cancer	2.33e-05	0.000288	CbGpPWpGaD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—lung cancer	2.32e-05	9.53e-05	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—lung cancer	2.32e-05	9.51e-05	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—APOA1—lung cancer	2.31e-05	0.000286	CbGpPWpGaD
Ofloxacin—Pain—Doxorubicin—lung cancer	2.3e-05	9.44e-05	CcSEcCtD
Ofloxacin—Constipation—Doxorubicin—lung cancer	2.3e-05	9.44e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	2.3e-05	0.000285	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—lung cancer	2.29e-05	0.000284	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Methotrexate—lung cancer	2.29e-05	9.39e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CCND1—lung cancer	2.28e-05	0.000282	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NCOA3—lung cancer	2.26e-05	0.00028	CbGpPWpGaD
Ofloxacin—Asthenia—Methotrexate—lung cancer	2.23e-05	9.14e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	2.23e-05	0.000276	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.22e-05	0.000275	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Doxorubicin—lung cancer	2.22e-05	9.09e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CDKN1A—lung cancer	2.21e-05	0.000273	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Doxorubicin—lung cancer	2.2e-05	9.02e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ABCG2—lung cancer	2.2e-05	0.000272	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ADCY1—lung cancer	2.2e-05	0.000272	CbGpPWpGaD
Ofloxacin—Pruritus—Methotrexate—lung cancer	2.2e-05	9.02e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—APP—lung cancer	2.17e-05	0.000269	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FGF9—lung cancer	2.16e-05	0.000267	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ENO2—lung cancer	2.16e-05	0.000267	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HPGDS—lung cancer	2.16e-05	0.000267	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPP2R1B—lung cancer	2.14e-05	0.000265	CbGpPWpGaD
Ofloxacin—Urticaria—Doxorubicin—lung cancer	2.14e-05	8.77e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—lung cancer	2.13e-05	8.72e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Doxorubicin—lung cancer	2.13e-05	8.72e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Methotrexate—lung cancer	2.12e-05	8.72e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.11e-05	0.000262	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	2.1e-05	0.00026	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—EP300—lung cancer	2.1e-05	0.00026	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ATP5H—lung cancer	2.1e-05	0.00026	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTT1—lung cancer	2.09e-05	0.000259	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—POMC—lung cancer	2.09e-05	0.000259	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP2A6—lung cancer	2.07e-05	0.000256	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GCLC—lung cancer	2.07e-05	0.000256	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—JUNB—lung cancer	2.06e-05	0.000255	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.06e-05	0.000255	CbGpPWpGaD
Ofloxacin—Dizziness—Methotrexate—lung cancer	2.05e-05	8.43e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	2.05e-05	0.000253	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	2.04e-05	0.000253	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Doxorubicin—lung cancer	1.98e-05	8.13e-05	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—CREBBP—lung cancer	1.98e-05	0.000245	CbGpPWpGaD
Ofloxacin—Vomiting—Methotrexate—lung cancer	1.97e-05	8.1e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ENO1—lung cancer	1.96e-05	0.000243	CbGpPWpGaD
Ofloxacin—Rash—Methotrexate—lung cancer	1.96e-05	8.03e-05	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.96e-05	0.000242	CbGpPWpGaD
Ofloxacin—Dermatitis—Methotrexate—lung cancer	1.96e-05	8.03e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.95e-05	0.000242	CbGpPWpGaD
Ofloxacin—Headache—Methotrexate—lung cancer	1.95e-05	7.98e-05	CcSEcCtD
Ofloxacin—Asthenia—Doxorubicin—lung cancer	1.93e-05	7.92e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.93e-05	0.000239	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	1.93e-05	0.000239	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	1.91e-05	0.000237	CbGpPWpGaD
Ofloxacin—Pruritus—Doxorubicin—lung cancer	1.9e-05	7.81e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—MAPK3—lung cancer	1.88e-05	0.000233	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLBD1—lung cancer	1.87e-05	0.000231	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—lung cancer	1.85e-05	0.000229	CbGpPWpGaD
Ofloxacin—Nausea—Methotrexate—lung cancer	1.84e-05	7.57e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Doxorubicin—lung cancer	1.84e-05	7.55e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	1.84e-05	0.000228	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—lung cancer	1.83e-05	0.000227	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—lung cancer	1.83e-05	0.000227	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FOXO3—lung cancer	1.8e-05	0.000223	CbGpPWpGaD
Ofloxacin—Dizziness—Doxorubicin—lung cancer	1.78e-05	7.3e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CYP2E1—lung cancer	1.76e-05	0.000218	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NQO1—lung cancer	1.74e-05	0.000215	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	1.73e-05	0.000214	CbGpPWpGaD
Ofloxacin—Vomiting—Doxorubicin—lung cancer	1.71e-05	7.02e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—HSD17B10—lung cancer	1.71e-05	0.000212	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.7e-05	0.000211	CbGpPWpGaD
Ofloxacin—Rash—Doxorubicin—lung cancer	1.7e-05	6.96e-05	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—lung cancer	1.69e-05	6.95e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.69e-05	0.000209	CbGpPWpGaD
Ofloxacin—Headache—Doxorubicin—lung cancer	1.68e-05	6.91e-05	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	1.68e-05	0.000208	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—RAF1—lung cancer	1.66e-05	0.000205	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HES1—lung cancer	1.6e-05	0.000198	CbGpPWpGaD
Ofloxacin—Nausea—Doxorubicin—lung cancer	1.6e-05	6.55e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—CKB—lung cancer	1.59e-05	0.000197	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—STK11—lung cancer	1.57e-05	0.000194	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—lung cancer	1.5e-05	0.000186	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ERCC2—lung cancer	1.49e-05	0.000185	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM2—lung cancer	1.49e-05	0.000185	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CNDP2—lung cancer	1.49e-05	0.000185	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.47e-05	0.000182	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ERBB3—lung cancer	1.46e-05	0.000181	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTMR3—lung cancer	1.45e-05	0.00018	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTP1—lung cancer	1.45e-05	0.000179	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PGAM1—lung cancer	1.42e-05	0.000175	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAT—lung cancer	1.41e-05	0.000175	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.4e-05	0.000174	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TERT—lung cancer	1.4e-05	0.000173	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCB1—lung cancer	1.37e-05	0.00017	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FGFR1—lung cancer	1.36e-05	0.000168	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2A7—lung cancer	1.35e-05	0.000167	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TYMS—lung cancer	1.35e-05	0.000167	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIF1A—lung cancer	1.34e-05	0.000166	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTM1—lung cancer	1.33e-05	0.000165	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SDC4—lung cancer	1.32e-05	0.000164	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOA1—lung cancer	1.29e-05	0.00016	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1A1—lung cancer	1.26e-05	0.000156	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ERCC2—lung cancer	1.25e-05	0.000155	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTA3—lung cancer	1.2e-05	0.000149	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—RRM1—lung cancer	1.2e-05	0.000149	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KIT—lung cancer	1.18e-05	0.000146	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APC—lung cancer	1.18e-05	0.000146	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGF—lung cancer	1.17e-05	0.000144	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—B4GALT5—lung cancer	1.13e-05	0.00014	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BRAF—lung cancer	1.11e-05	0.000137	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTA4—lung cancer	1.1e-05	0.000136	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6R—lung cancer	1.1e-05	0.000136	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CREBBP—lung cancer	1.09e-05	0.000136	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOA1—lung cancer	1.08e-05	0.000134	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.08e-05	0.000133	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTA2—lung cancer	1.07e-05	0.000133	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAP2K1—lung cancer	1.04e-05	0.000129	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CD—lung cancer	1.04e-05	0.000128	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.04e-05	0.000128	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTA1—lung cancer	1.04e-05	0.000128	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCC3—lung cancer	1.02e-05	0.000127	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKR1C1—lung cancer	9.92e-06	0.000123	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CG—lung cancer	9.89e-06	0.000122	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—UGT1A1—lung cancer	9.63e-06	0.000119	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—POMC—lung cancer	9.41e-06	0.000117	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MDM2—lung cancer	9.3e-06	0.000115	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GNG11—lung cancer	9.28e-06	0.000115	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RAF1—lung cancer	9.26e-06	0.000115	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.23e-06	0.000114	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CREBBP—lung cancer	9.17e-06	0.000113	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ERBB2—lung cancer	9.17e-06	0.000113	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CB—lung cancer	9.05e-06	0.000112	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTOR—lung cancer	9.05e-06	0.000112	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD4—lung cancer	9.03e-06	0.000112	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—lung cancer	8.96e-06	0.000111	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALDOA—lung cancer	8.84e-06	0.000109	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CD—lung cancer	8.69e-06	0.000108	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NCOA3—lung cancer	8.58e-06	0.000106	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—lung cancer	8.58e-06	0.000106	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.43e-06	0.000104	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADCY1—lung cancer	8.35e-06	0.000103	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCG2—lung cancer	8.35e-06	0.000103	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HPGDS—lung cancer	8.18e-06	0.000101	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ENO2—lung cancer	8.18e-06	0.000101	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPP2R1B—lung cancer	8.13e-06	0.000101	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.03e-06	9.94e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTT1—lung cancer	7.94e-06	9.83e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GCLC—lung cancer	7.85e-06	9.72e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2A6—lung cancer	7.85e-06	9.72e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1A—lung cancer	7.83e-06	9.7e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.82e-06	9.68e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTEN—lung cancer	7.82e-06	9.68e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CB—lung cancer	7.58e-06	9.38e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—lung cancer	7.51e-06	9.29e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EP300—lung cancer	7.45e-06	9.23e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ENO1—lung cancer	7.44e-06	9.21e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.41e-06	9.18e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.32e-06	9.06e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SRC—lung cancer	7.25e-06	8.98e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—lung cancer	6.99e-06	8.66e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NRAS—lung cancer	6.97e-06	8.63e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK3—lung cancer	6.68e-06	8.27e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2E1—lung cancer	6.67e-06	8.26e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NQO1—lung cancer	6.6e-06	8.17e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTEN—lung cancer	6.55e-06	8.11e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—lung cancer	6.5e-06	8.04e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.46e-06	8e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.4e-06	7.93e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—lung cancer	6.35e-06	7.87e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—EP300—lung cancer	6.24e-06	7.73e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KRAS—lung cancer	6e-06	7.43e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—STK11—lung cancer	5.95e-06	7.36e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.58e-06	6.91e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—lung cancer	5.51e-06	6.83e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTP1—lung cancer	5.5e-06	6.81e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAT—lung cancer	5.35e-06	6.63e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.32e-06	6.59e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCB1—lung cancer	5.21e-06	6.45e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TYMS—lung cancer	5.12e-06	6.33e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HRAS—lung cancer	5.1e-06	6.32e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM1—lung cancer	5.06e-06	6.26e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—lung cancer	4.88e-06	6.05e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP1A1—lung cancer	4.79e-06	5.94e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ERCC2—lung cancer	4.75e-06	5.89e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—lung cancer	4.62e-06	5.72e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—lung cancer	4.5e-06	5.58e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOA1—lung cancer	4.11e-06	5.09e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.94e-06	4.88e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—lung cancer	3.77e-06	4.67e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CG—lung cancer	3.75e-06	4.65e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—POMC—lung cancer	3.57e-06	4.43e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CREBBP—lung cancer	3.48e-06	4.31e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CD—lung cancer	3.3e-06	4.09e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—lung cancer	3.26e-06	4.03e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CB—lung cancer	2.88e-06	3.56e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—lung cancer	2.85e-06	3.53e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTEN—lung cancer	2.49e-06	3.08e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—EP300—lung cancer	2.37e-06	2.94e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—lung cancer	1.75e-06	2.17e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—lung cancer	1.43e-06	1.77e-05	CbGpPWpGaD
